Obstetrics/Gynecology
RSSArticles
-
Laborists: How Will It Affect Care?
A recent study has shown a decrease in rates of induction, cesarean section, and preterm birth in hospitals after instituting a laborist model, compared with matched-control hospitals using the traditional model.
-
Who Needs an Endometrial Biopsy?
In this retrospective cohort study of premenopausal women with abnormal uterine bleeding, obesity, as opposed to age, was the most significant predictor of complex hyperplasia or cancer on endometrial biopsy.
-
Did You Remember to Take Your Hormone Replacement? The Treatment May Not Help
Women randomized to receive postmenopausal oral estradiol therapy did not show improved memory, executive function, or global cognition, and timing of initiation of hormonal treatment did not affect the outcome.
-
Reproductive Health and Rights Face Period of Crisis
The Trump administration and the 115th Congress will have powerful levers at their disposal to roll back decades’ worth of progress in sexual and reproductive health and rights.
-
Offer Reproductive Life Planning for Adolescents
The CDC recommends all persons capable of having a child create a reproductive life plan.
-
Research Looks at Antibiotic Option for Gonorrhea
A drug under investigation could be used as an alternative to ceftriaxone injection as a component of recommended therapy for gonorrhea, replacing the need for intramuscular injection.
-
College Health Services Are Making the Grade
College health centers are playing a pivotal role in the introduction and performance of timely sexually transmitted infection screenings.
-
Does Weight Gain Play a Role in Women’s Contraceptive Choices?
Concerns about weight gain may be driving contraception choices, new data released by Penn State College of Medicine indicate.
-
LARC for the Medically Complicated Patient
Few medical conditions are absolute contraindications to long-acting reversible contraceptive methods.
-
Extending Life of LARCs: More Years for Your Implant
An international study found that continued use of an etonogestrel contraceptive implant for up to five years, two years longer than the current labeling approval, did not increase the risk of pregnancy.